The use of the enzyme chitosanase to enable vaccine potency determination in a formulation containing the adjuvant chitosan.

Saved in:
Bibliographic Details
Title: The use of the enzyme chitosanase to enable vaccine potency determination in a formulation containing the adjuvant chitosan.
Authors: Fox N; MRL, Merck & Co., Inc., Rahway, NJ, USA., Trausch JJ; MRL, Merck & Co., Inc., Rahway, NJ, USA. Electronic address: jeremiah.trausch@merck.com., Yarovoi H; MRL, Merck & Co., Inc., Rahway, NJ, USA., Stiving AQ; MRL, Merck & Co., Inc., Rahway, NJ, USA., Bowman A; MRL, Merck & Co., Inc., Rahway, NJ, USA., Smith ML; MRL, Merck & Co., Inc., Rahway, NJ, USA., Liu Y; MRL, Merck & Co., Inc., Rahway, NJ, USA., Eddins MJ; MRL, Merck & Co., Inc., Rahway, NJ, USA., Loughney JW; MRL, Merck & Co., Inc., Rahway, NJ, USA., Mayhood T; MRL, Merck & Co., Inc., Rahway, NJ, USA., Paduraru C; MRL, Merck & Co., Inc., Rahway, NJ, USA., Grau B; MRL, Merck & Co., Inc., Rahway, NJ, USA.
Source: Journal of pharmaceutical sciences [J Pharm Sci] 2026 Oct; Vol. 115 (10), pp. 104461. Date of Electronic Publication: 2026 Aug 15.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 2985195R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-6017 (Electronic) Linking ISSN: 00223549 NLM ISO Abbreviation: J Pharm Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1520-6017
DOI:10.1016/j.xphs.2026.104461